Global pharmaceutical giant Pfizer is starting trials of a potential COVID-19 vaccine in New York and Maryland, and the clinical trial supply is being produced in suburban St. Louis and in Massachusetts. Pfizer is partnering with Germany's BioNTech on the manufacturing of the possible vaccine. The first participants in the testing of the vaccine have already had their first dose. More candidates are being sought for more testing in Cincinnati and Rochester, New York.